Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275729
Max Phase: Preclinical
Molecular Formula: C45H45NO23
Molecular Weight: 967.84
Associated Items:
ID: ALA5275729
Max Phase: Preclinical
Molecular Formula: C45H45NO23
Molecular Weight: 967.84
Associated Items:
Canonical SMILES: COC(=O)CC[C@H](NC(=O)COc1c(OC(C)=O)cc(C(=O)O[C@@H]2Cc3c(OC(C)=O)cc(OC(C)=O)cc3O[C@@H]2c2cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O)C(=O)OC
Standard InChI: InChI=1S/C45H45NO23/c1-20(47)61-29-16-32(62-21(2)48)30-18-38(41(68-33(30)17-29)27-12-36(65-24(5)51)43(67-26(7)53)37(13-27)66-25(6)52)69-44(56)28-14-34(63-22(3)49)42(35(15-28)64-23(4)50)60-19-39(54)46-31(45(57)59-9)10-11-40(55)58-8/h12-17,31,38,41H,10-11,18-19H2,1-9H3,(H,46,54)/t31-,38+,41+/m0/s1
Standard InChI Key: WKYJEWIDKSJWKB-MSHCONSHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 967.84 | Molecular Weight (Monoisotopic): 967.2382 | AlogP: 3.06 | #Rotatable Bonds: 18 |
Polar Surface Area: 310.56 | Molecular Species: NEUTRAL | HBA: 23 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 24 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.17 | CX Basic pKa: | CX LogP: 1.48 | CX LogD: 1.48 |
Aromatic Rings: 3 | Heavy Atoms: 69 | QED Weighted: 0.11 | Np Likeness Score: 0.57 |
1. Lee H, Jeong JH, Lee T, Chong Y, Choo H, Lee S.. (2023) Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway., 90 [PMID:37182610] [10.1016/j.bmcl.2023.129325] |
Source(1):